Psychiatry and Neurology, Neurology · Fort Wayne, IN
NPI
1487651873
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
7956 W Jefferson Blvd
Fort Wayne, IN, 46804
Phone (260) 436-2416
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
171,262 services
Medicare patients, 2024
367
Average age 71
Drug cost, 2024
$3.5M
2,521 prescriptions
Company payments, 2025
$44K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ajay S Gupta was code J0174 (injection, lecanemab-irmb, 1 mg), 120,671 times for 37 patients. In total Ajay S Gupta billed 171,262 services in 67 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0174 Injection, lecanemab-irmb, 1 mg | Office | 120,671 | 37 | $1.05 | $126K |
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,030 | 19 | $4.51 | $41K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,320 | 15 | $0.26 | $344 |
| 96365 Intravenous Infusion, Hydration | Office | 210 | 67 | $44.50 | $9,346 |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 187 | 69 | $1.00 | $188 |
| 99213 Office E&M - Established | Office | 104 | 86 | $46.44 | $4,830 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 95 | 92 | $10.78 | $1,024 |
| 99214 Office E&M - Established | Office | 76 | 61 | $73.58 | $5,592 |
| 96413 Chemotherapy Administration | Office | 60 | 13 | $81.63 | $4,898 |
| 96374 Injection Administration | Office | 43 | 18 | $26.61 | $1,144 |
| 95885 Electrical Nerve Conductivity | Office | 41 | 23 | $40.00 | $1,640 |
| 95874 Musculoskeletal | Office | 39 | 16 | $48.13 | $1,877 |
| 99232 Hospital E&M - Subsequent | Facility | 35 | 28 | $52.89 | $1,851 |
| 95886 Electrical Nerve Conductivity | Office | 34 | 24 | $57.10 | $1,941 |
| 99203 Office E&M - New | Office | 30 | 30 | $63.49 | $1,905 |
By year: 2022 $315K for 16,288 services; 2023 $1.7M for 65,230 services; 2024 $1.7M for 171,262 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ajay S Gupta prescribed most often to Medicare patients was Baclofen, with 233 prescriptions and refills. In total Ajay S Gupta wrote 2,521 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 233 | 407 | 42 | $4,781 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 159 | 312 | 36 | $2,551 |
| Gabapentin Generic | 149 | 311 | 48 | $3,461 |
| Topiramate Generic | 124 | 216 | 32 | $1,106 |
| Donepezil Hcl Generic | 120 | 250 | 37 | $704 |
| Primidone Generic | 84 | 142 | 25 | $2,124 |
| Teriflunomide Generic | 80 | 112 | Under 11 | $125K |
| Kesimpta Pen Ofatumumab | 78 | 78 | Under 11 | $693K |
| Duloxetine Hcl Generic | 73 | 150 | 17 | $1,544 |
| Memantine Hcl Generic | 68 | 106 | 18 | $1,426 |
| Leflunomide Generic | 66 | 134 | 15 | $3,923 |
| Sertraline Hcl Generic | 64 | 134 | 17 | $267 |
| Trazodone Hcl Generic | 58 | 126 | 14 | $395 |
| Dimethyl Fumarate Generic | 51 | 55 | Under 11 | $11K |
| Dalfampridine Er Dalfampridine | 48 | 74 | Under 11 | $11K |
Brand drugs: 368 claims; generic drugs: 2,153 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ajay S Gupta $44K ($44K in general payments such as food, travel and fees) from 9 companies. The largest payer was EMD Serono, Inc. with $36K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.